These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23023352)

  • 21. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.
    Chen S; Gu H; Sun C; Wang H; Wang J
    Infection; 2017 Jun; 45(3):255-262. PubMed ID: 27601055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
    Napierala M; Munson E; Skonieczny P; Rodriguez S; Riederer N; Land G; Luzinski M; Block D; Hryciuk JE
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):534-8. PubMed ID: 23731555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
    Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.
    Rüssmann H; Panthel K; Bader RC; Schmitt C; Schaumann R
    Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):115-9. PubMed ID: 17211606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.
    Lozniewski A; Rabaud C; Dotto E; Weber M; Mory F
    J Clin Microbiol; 2001 May; 39(5):1996-8. PubMed ID: 11326033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
    Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
    Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative performance of the GeneXpert C. difficile PCR assay and C. diff Quik Chek Complete kit assay for detection of Clostridium difficile antigen and toxins in symptomatic community-onset infections.
    Jamal W; Pauline EM; Rotimi VO
    Int J Infect Dis; 2014 Dec; 29():244-8. PubMed ID: 25462186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.
    Guerrero DM; Chou C; Jury LA; Nerandzic MM; Cadnum JC; Donskey CJ
    Clin Infect Dis; 2011 Aug; 53(3):287-90. PubMed ID: 21765078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.
    Patel H; Randhawa J; Nanavati S; Marton LR; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2015; 45(3):333-9. PubMed ID: 26116599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens.
    Caulfield AJ; Bolster LaSalle CM; Chang YH; Grys TE
    Diagn Microbiol Infect Dis; 2018 May; 91(1):1-5. PubMed ID: 29428547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor yield of Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays in a pediatric population with declining prevalence of clostridium difficile strain BI/NAP1/027.
    Gomez EJ; Montgomery S; Alby K; Robinson DP; Roundtree SS; Blecker-Shelly D; Sullivan KV
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):229-232. PubMed ID: 29567127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective.
    McConnie R; Kastl A
    Curr Gastroenterol Rep; 2017 Aug; 19(8):34. PubMed ID: 28707191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of analytical and clinical performance of three methods for detection of Clostridium difficile.
    LaSala PR; Svensson AM; Mohammad AA; Perrotta PL
    Arch Pathol Lab Med; 2012 May; 136(5):527-31. PubMed ID: 22540301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-stage algorithm for Clostridium difficile: glutamate-dehydrogenase-positive toxin-negative enzyme immunoassay results may require further testing.
    Bignardi GE; Hill K; Berrington A; Settle CD
    J Hosp Infect; 2013 Apr; 83(4):347-9. PubMed ID: 23399483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.